Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES (GILD)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on GILEAD SCIENCES
12/14/17 ex-dividend day
02/06/18 FY 2017 Earnings Release (Projected)
Past events on GILEAD SCIENCES
12/06/17 | 09:15am NASDAQ Investor Conference
11/07/17 | 08:30pm Credit Suisse Health Care Conference
11/03/17 American College of Rheumatology Meeting
10/26/17 | 10:30pm Q3 2017 Earnings Call
Upcoming sector events for GILEAD SCIENCES
12/12/17 JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #4471
12/12/17 BLUEBIRD BIO INC : American Society of Hematology Meeting - Abstract #3557
12/12/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #1636
12/12/17 | 02:15am SEATTLE GENETICS, INC. : American Society of Hematology Meeting
Past sector events for GILEAD SCIENCES
12/11/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #2896
12/11/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #2585
12/11/17 | 09:00pm BLUEBIRD BIO INC : American Society of Hematology Meeting - Abstract #740
12/11/17 | 10:30pm JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #805
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million $
Released
Forecast
Spread
24 890
24 300
2,4%
32 639
32 260
1,2%
30 390
30 212
0,59%

25 816

22 256
Operating income (EBITDA)
Million $
Released
Forecast
Spread
16 794
17 148
-2,1%
23 668
24 049
-1,6%
20 347
20 987
-3,0%

16 736

13 288
Operating profit (EBIT)
Million $
Released
Forecast
Spread
16 580
16 153
2,6%
23 396
22 737
2,9%
20 033
20 005
0,14%

15 661

12 498
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
12 101
11 917
1,5%
18 108
17 770
1,9%
13 501
14 145
-4,6%

10 511

7 689
EPS
 $
Released
Forecast
Spread
7,35
7,25
1,4%
11,9
11,5
3,5%
9,94
10,3
-3,0%

7,78

5,97
Announcement Date02/03/201502/02/201602/07/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsQ1
2017
Q2
2017
Q3
2017
Q4
2017 (e)
Q1
2018 (e)
Sales
Million $
Released
Forecast
Spread
6 505
6 633
-1,9%
7 141
6 354
12%
6 512
6 393
1,9%

5 719

5 691
Operating income (EBITDA)
Million $
Released
Forecast
Spread
4 115
4 437
-7,3%
4 698
4 047
16%
4 228
4 264
-0,84%

3 326


Operating profit (EBIT)
Million $
Released
Forecast
Spread
4 066
4 200
-3,2%
4 610
3 953
17%
4 140
3 931
5,3%

3 043

2 843
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
2 702
2 741
-1,4%
3 073
2 567
20%
2 718
2 578
5,4%

1 912

1 821
EPS
 $
Released
Forecast
Spread
2,05
2,06
-0,59%
2,33
1,97
18%
2,06
1,95
5,7%

1,48

1,40
Announcement Date05/02/201707/26/201710/26/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
Operating profit (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise